NANOVISION GROUP
The nanotechnology revolution in the ophthalmology world
Boston, MA -- NANOVISION GROUP, a company founded in Russia in 2011, announced at the annual meeting of the American Society of Cataract and Refractive Surgery that it plans to begin extensive commercialization in Europe and Asia in the 3rd quarter of 2014.
NANOVISION GROUP (NVG) has already begun to establish its name with state of the art manufacturing facilities in Russia coupled with strong strategic partnerships worldwide. It plans to market innovative intraocular lenses, refractive surgery laser equipment and the first independent network of eye banks in Eastern Europe. The company has developed the first concept of a universal femtosecond laser for cataract and refractive surgery as well as nanotechnology applications to combat the major challenges in refractive surgery, ophthalmic drugs delivery and patient adherence.
Founded by Dimitry Dementiev, MD, the Chairman of the Board and the Chief Medical Investigator, and Anton Archipov, President and CEO, NANOVISION GROUP is a cutting edge Russian company well-versed in the latest international standards. Both Dr. Dementiev and Mr. Archipov have extensive global experience in ophthalmology and have decided to return their expertise to Russia to enable Russian technology to get back in the driving seat.
“We strive to help patients who suffer from vision dysfunctions and eye pathology of various etiologies. For 20 years and up to the beginning of the 1990s, Russia was a leader in refractive surgery. NanoVision is here to relaunch this ophthalmology tradition,” said Dr. Dementiev, who studied ophthalmic surgery directly with Prof. Svyatoslav Fedorov in the early 1980s.
“Our core business strategy is to support high-end, innovative, medical device manufacturing and applied ophthalmic research. The Group is well integrated with the international research and development environment. Money is no object with the only criteria being that results must be competitively advantageous on the global scale. The corporate portfolio already includes a number of projects related to intraocular lenses, contact lenses, drug delivery devices, novel laser systems and applications for ophthalmology," says Anton Arkhipov, whose passion for ophthalmology was planted by Prof. Ioannis Pallikaris in the late 1990s.
Four Areas of Focus
The company is structured in four areas – research and development, IOLs, lasers and eye banking - with plans for the lasers to be the first products commercialized internationally in September 2014. The excimer VISUM 500® and FEMTO-VISUM® platforms are already on the market in Russia and China. The European focus will be on select markets during the initial commercial rollout.
Research and Development
NVG’s research and development efforts focus on the application of nanotechnologies in ophthalmology. This work is being profiled by the company’s Medical Advisory Board that is comprised of leading ophthalmologists including Dr. Dementiev (Italy / Russia), Prof. Jorge Alio (Spain), Prof. Ioannis Pallikaris (Greece), Prof. Anselm Kampik (Germany), Matteo Piovella, MD (Italy), Prof. Ken Hoffer, MD (USA), Tatiana Naoumidi, MD (Greece), Prof. Igor Solomatins (Latvia) and Prof. Nikolai Pashtaev (Russia).
LASERS
“The "open type" cavity design and the laser technique using two-quantum transitions widely used today were born in Russia and awarded the Nobel Prize in Physics in 1964. With their pioneering work on lasers and masers, Alexander Prokhorov along with Nikolay Basov and Charles Hard Townes created the grounds for most of the contemporary laser applications ”, says Dr. Sergey Vartapetov, one of the first students of Alexander Prokhorov, He leads OptoSystems Ltd., the laser division of NANOVISION GROUP built on the foundation of the Nobel prize-winning work. The femtosecond laser for cataract surgery will be introduced internationally in 2015.
IOLs
The launch of the lasers will be followed by a full catalogue of premium quality hydrophobic and hydrophilic IOLs that are manufactured using nanotechnology and featuring increased optical field along with proprietary edge design. Delivery systems will be nano-tailored for each specific lens to allow folding and unfolding in a very small space This will permit surgeons to perform a micro-incision of as little as 1.8 mm.
iLabs®
The company has also established iLabs®, the first independent network of eye banks in Eastern Europe, which allows manufacturing and storage of tissue for corneal transplantation. The bank is affiliated with the International Sight Restoration Eye Bank in Tampa, Florida, the largest corneal tissue logistical center in the US, and tissue quality control may be performed online in both Russia and the United States.
NanoVision LLC, Russia
Berezovaya Alleya str. 5A, 127273 Moscow, Russia
Tel. +7 (495) 287.75.42
www.nanovisiongroup.com
To learn more about NANOVISION GROUP or to schedule an interview with a member of the management team, please contact Giorgio Pirazzini at: [email protected] or [email protected]